Skip to main content

Advertisement

SpringerLink
Log in

Expression of EMSY gene in sporadic ovarian cancer

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The majority of familial breast and ovarian cancers arise from mutations in the BRCA1 and BRCA2 genes. Amplification at the 11q13.5 locus is commonly observed in breast and ovarian cancers. In 2003, Hughes-Davies et al. identified a novel gene (EMSY) at this locus which binds BRCA2 within a region deleted in some cancers. Although little is known about the cellular role of EMSY, indirect evidence suggests that this nuclear protein is capable of silencing the activation potential of BRCA2. In this study we aimed to investigate expression of the EMSY gene and its protein product in sporadic ovarian cancer. Real-time quantitative RT-PCR was performed in 50 ovarian cancer and 17 normal ovarian tissue samples. Overexpression of the EMSY gene was found in 6/50 cases (12%), but in none of the control samples. To determine the EMSY protein by Western blotting, semi-quantitative analysis of the EMSY protein was performed using the Scion Image Gel Analysis Program. Statistical analysis was performed using SPSS 11.5. All patients having EMSY overexpression also displayed increased levels of the EMSY protein. Sporadic ovarian cancer shows overexpression of EMSY at a prevalence similar to that found in breast cancer and the overexpression is correlated with the protein level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics. CA Cancer J Clin 51:15–36

    Article  CAS  PubMed  Google Scholar 

  2. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334:1–6

    Article  CAS  PubMed  Google Scholar 

  3. Goff BA, Mandel LS, Melancon CH, Muntz HG (2004) Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 291:2705–2712

    Article  CAS  PubMed  Google Scholar 

  4. Cannistra SA (1993) Cancer of the ovary. N Engl J Med 329:1550–1559

    Article  CAS  PubMed  Google Scholar 

  5. Runnowicz CD, Fields AL (1999) Screening for gynecologic malignancies: a continuing responsibility. Surg Oncol Clin N Am 8:703–724

    Google Scholar 

  6. Bast RC Jr (2003) Status of tumor markers in ovarian cancer screening. J Clin Oncol 21:200–205

    Article  Google Scholar 

  7. Sidransky D (2002) Emerging molecular markers of cancer. Nat Rev Cancer 2:210–219

    Article  CAS  PubMed  Google Scholar 

  8. Dehaghani AS, Shahriary K, Kashef MA, Naeimi S, Fattahi MJ, Mojtahedi Z, Ghaderi A (2009) Interleukin-18 gene promoter and serum level in women with ovarian cancer. Mol Biol Rep 36:2393–2397

    Article  Google Scholar 

  9. Xu F, Wang G, Cai K, Zhai R, Tang S (2010) Effects of ovariectomy on microsatellite instability in rat colon tumors induced by 1,2-dimethylhydrazine. Mol Biol Rep 37:1397–1401

    Article  CAS  PubMed  Google Scholar 

  10. Liao R-Y, Mao C, Qiu L-X, Ding H, Chen Q, Pan H-F (2009) TGFBR1*6A/9A polymorphism and cancer risk: a meta analysis of 13,662 cases and 14,147 controls. Mol Biol Rep. doi:10.1007/s11033-009-9906-7

  11. Boyd J (1998) Molecular genetics of hereditary ovarian cancer. Oncology (Huntingt) 12:399–406

    CAS  Google Scholar 

  12. Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, Chan VW, Au GK, Ng WF, Poon CS, Leung YF, Loong F, Ip P, Chan GS, Andrulis IL, Lu J, Ho FC (1999) Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer. Oncogene 18:4643–4646

    Article  CAS  PubMed  Google Scholar 

  13. Hosking L, Trowsdale J, Nicolai H, Solomon E, Foulkes W, Stamp G, Signer E, Jeffreys A (1995) A somatic BRCA1 mutation in an ovarian tumor. Nat Genet 9:343–344

    Article  CAS  PubMed  Google Scholar 

  14. Dobrovick A, Simpfendorfer D (1997) Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57:3347–3350

    Google Scholar 

  15. Wilson CA, Ramos L, Villasenar MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ (1999) Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 21:236–240

    Article  CAS  PubMed  Google Scholar 

  16. Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, Chia S, Ragaz J, Cahn A, Linger L, Ozdag H, Cattaneo E, Jordanova ES, Schuuring E, Yu DS, Venkitaraman A, Ponder B, Doherty A, Aparicio S, Bentley D, Theillet C, Ponting CP, Caldas C, Kouzarides T (2003) EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 115:523–535

    Article  CAS  PubMed  Google Scholar 

  17. Hilton JL, Geisler JP, Rathe JA, Zogg H, DeYoung B, Buller RE (2002) Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst 94:1396–1406

    CAS  PubMed  Google Scholar 

  18. Ekblad CM, Chavali GB, Basu BP, Freund SM, Veprintsev D, Hughes-Davies L, Kouzarides T, Doherty AJ, Itzhaki LS (2005) Binding of EMSY to HP1β: implications for recruitment of HP1β and BS69. EMBO Rep 6:675–680

    Article  CAS  PubMed  Google Scholar 

  19. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–2324

    Article  CAS  PubMed  Google Scholar 

  20. Karlseder J, Zeillinger R, Schneeberger C, Czerwenka K, Speiser P, Kubista E, Birnbaum D, Gaudray P, Theillet C (1994) Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosom Cancer 9:42–48

    Article  CAS  PubMed  Google Scholar 

  21. Bekri S, Adélaïde J, Merscher S, Grosgeorge J, Caroli-Bosc F, Perucca-Lostanlen D, Kelley PM, Pébusque MJ, Theillet C, Birnbaum D, Gaudray P (1997) Detailed map of a region commonly amplified at 11q13 → q14 in human breast carcinoma. Cytogenet Cell Genet 79:125–131

    Article  CAS  PubMed  Google Scholar 

  22. Schraml P, Schwerdtfeger G, Burkhalter F, Raggi A, Schmidt D, Ruffalo T, King W, Wilber K, Mihatsch MJ, Moch H (2003) Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5–q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 163:985–992

    CAS  PubMed  Google Scholar 

  23. Nordling M, Karlsson P, Wahlström J, Engwall Y, Wallgren A, Martinsson T (1998) A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. Cancer Res 58:1372–1375

    CAS  PubMed  Google Scholar 

  24. Rodriguez C, Hughes-Davies L, Vallès H, Orsetti B, Cuny M, Ursule L, Kouzarides T, Theillet C (2004) Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome. Clin Cancer Res 10:5785–5791

    Article  CAS  PubMed  Google Scholar 

  25. Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, Chia S, Magliocco A, Makretsov N, Gilks B, Pollack J, Huntsman D (2006) Amplification of EMSY, a novel oncogene on 11q13 in high grade ovarian surface epithelial carcinomas. Gynecol Oncol 100:264–270

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The present work was supported by the Research Fund of Istanbul University. Project No. T-728/13092005 and by TUBITAK. Project No. SBAG-HD-172 (106S254).

Author information

Authors and Affiliations

  1. Cerrahpasa Medical Faculty, Department of Medical Biology, Istanbul University, Istanbul, Turkey

    Julide Altinisik, Turgut Ulutin & Nur Buyru

  2. Department of Gynecology and Obstetrics, Zeynep Kamil Maternity and Child Research and Training Hospital, Istanbul, Turkey

    Ates Karateke & Hakan Coksuer

Authors
  1. Julide Altinisik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ates Karateke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hakan Coksuer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Turgut Ulutin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nur Buyru
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nur Buyru.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Altinisik, J., Karateke, A., Coksuer, H. et al. Expression of EMSY gene in sporadic ovarian cancer. Mol Biol Rep 38, 359–363 (2011). https://doi.org/10.1007/s11033-010-0116-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0116-0

Keywords

Search

Navigation